top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Anticancer Agents : Design, Synthesis and Evaluation
Anticancer Agents : Design, Synthesis and Evaluation
Autore Chen Qiao-Hong
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (606 p.)
Soggetto topico Medicine
Soggetto non controllato benzofurans
chemical synthesis
cytotoxic properties
HeLa
MOLT-4
K562
anticancer
anti-neuroinflammation
coumarin
dihydroartemisinin
flavonoids
allene
E-stereoselective
regioselective
anti-cancer activity
cyanopyridone
substituted pyridine
pyridotriazine
pyrazolopyridine
thioxotriazopyridine
anticancer activity
HepG2
antitumor activity
computational docking
MDM2-p53 interaction
xanthones
yeast-based assays
estrone derivatives
hydrazine
N-substituted pyrazoline
anti-ovarian cancer
topoisomerase II inhibitor
kinase inhibitor
antiproliferative agent
urea
synthesis
antiproliferative activity
apoptosis
indoleamine 2,3-dioxygenase
inhibitor
anti-tumor
immune modulation
tryptophan metabolism
taxoids
βIII-tubulin
P-glycoprotein
drug resistance
thiopene
thienopyrimidinone
thiazolidinone
breast cancer
benzofuran–pyrazole
nanoparticles
cytotoxic activity
PARP-1 inhibition
3,6-dibromocarbazole
5-bromoindole
carbazole
actin
migration
Thienopyrimidine
Pyrazole
PI3Kα inhibitor
quinazolin-4(3H)-one
quinazolin-4(3H)-thione
Schiff base
antioxidant activity
DFT study
ortho-quinones
beta-lapachone
tanshione IIA
PI3Ks
PI3Kδ inhibitors
2H-benzo[e][1,2,4]thiadiazine 1,1-dioxide
anticancer agents
protein–protein interactions
virtual screening
mimetics
drug discovery
bivalency
polyvalency
antitumor
cell cycle
ovarian cancer
P-MAPA
IL-12
TLR signaling
inflammation
chemoresistance
4-(pyridin-4-yloxy)benzamide
1,2,3-triazole
c-Met
natural product
anticancer agent
zampanolide
Talazoparib
PARP inhibitor
prodrug
o-nitro-benzyl
photoactivatable protecting groups
salinomycin
overcoming drug resistance
tumor specificity
synergy
5-fluorouracil
gemcitabine
amides/esters
colchicine analogs
thiocolchicine
colchiceine
antimitotic agents
hydrates
dihydropyranoindole
HDAC inhibitors
neuroblastoma
aromatase
MCF-7
NIH3T3
benzimidazole
triazolothiadiazine
docking
ADME
organosilicon compounds
SILA-409 (Alis-409)
SILA-421 (Alis-421)
multidrug resistance (MDR) reversal
ABCB1 (P-glycoprotein)
colon cancer
colchicine amide
colchicine sulfonamide
tubulin inhibitors
docking studies
crystal structure
PROTACs
protein degradation
IGF-1R
Src
protein kinase
phenylpyrazolopyrimidine
enzyme inhibition
molecular simulation
androgen receptor
prostate cancer
enzalutamide
apalutamide
darolutamide
triple-negative breast cancer
cytotoxicity
chrysin analogues
flavonoid
anticancer compounds
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Anticancer Agents
Record Nr. UNINA-9910557129103321
Chen Qiao-Hong  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Dual Specificity Phosphatases: From Molecular Mechanisms to Biological Function
Dual Specificity Phosphatases: From Molecular Mechanisms to Biological Function
Autore Pulido Rafael
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica 1 electronic resource (240 p.)
Soggetto non controllato hematopoietic cells
DEPArray
neuroblastoma
liver steatosis
MAPK phosphatase
DUSP-4
granule neurons
neuronal differentiation
DUSP10
cytokines
MAPKs
single cell analysis
macrophage
asthma
E. coli infection
MAPK
Cpp1
nucleotide receptors
atypical DUSP
RSV
Pmp1
cannabinoids
astrocytes
sepsis
influenza
signaling
triple-negative breast cancer (TNBC)
differentiation
HDAC6 (histone deacetylase isoform 6)
atypical dual-specificity phosphatases
microtubules
respiratory viruses
MK-STYX (MAPK (mitogen-activated protein kinase) phosphoserine/threonine/tyrosine-binding protein)
dual-specificity phosphatase
Msg5
TLR signaling
mitogen-activated protein kinase
fungal MKPs
macrophages
MAP Kinase Phosphatase-2
inflammation
Sdp1
circulating tumor cells (CTCs)
MAP kinases
MAP kinase phosphatases
P2X7
proliferation
BDNF
P2Y13
T cell
hypertriglyceridemia
integrated omics analysis
post-translational modification
rhinovirus
protein stability
ubiquitination
dual-specificity phosphatases
Mkp-1
cancer
brain metastasis
HER2
COPD
pseudophosphatase
ISBN 3-03921-689-9
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Dual Specificity Phosphatases
Record Nr. UNINA-9910367740903321
Pulido Rafael  
MDPI - Multidisciplinary Digital Publishing Institute, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Polyamine Metabolism in Disease and Polyamine-Targeted Therapies
Polyamine Metabolism in Disease and Polyamine-Targeted Therapies
Autore Murray-Stewart Tracy
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica 1 electronic resource (240 p.)
Soggetto non controllato protein synthesis in cancer
neuroblastoma
epigenetics
Drosophila imaginal discs
pneumococcal pneumonia
transgenic mice
spermidine/spermine N1-acetyl transferase
?-difluoromethylornithine
MYC
skeletal muscle
protein expression
curcumin
colorectal cancer
autophagy
human embryonic kidney 293 (HEK293)
melanoma
tumor immunity
Snyder-Robinson Syndrome
Streptococcus pneumoniae
B-lymphocytes
autoimmunity
spermine oxidase
cell differentiation
diferuloylmethane
immunity
antizyme
transgenic mouse
polyamine
hirsutism
chemoprevention
CRISPR
transglutaminase
polyamine analogs
NF-?B
spermine synthase
atrophy
aging
oxidative stress
mast cells
African sleeping sickness
pancreatic ductal adenocarcinoma
eflornithine
carcinogenesis
ornithine decarboxylase
polyamine transport inhibitor
putrescine
neutrophils
spermidine
untranslated region
spermine
polyphenol
M2 macrophages
polyamine transport system
metabolism
difluoromethylorthinine
DFMO
antizyme inhibitors
capsule
polyamine transport
eosinophils
MCF-7 cells
difluoromethylornithine
polyamine metabolism
mutant BRAF
polyamines
cadaverine
proteomics
airway smooth muscle cells
breast cancer
X-linked intellectual disability
complementation
T-lymphocytes
bis(ethyl)polyamine analogs
antizyme 1
cancer
osteosarcoma
ISBN 3-03921-153-6
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910367757003321
Murray-Stewart Tracy  
MDPI - Multidisciplinary Digital Publishing Institute, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Role of MicroRNA in Cancer Development and Treatment
Role of MicroRNA in Cancer Development and Treatment
Autore Pulliero Alessandra
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (280 p.)
Soggetto topico Medicine
Pharmacology
Soggetto non controllato breast cancer
miRNAs
liquid biopsy
angiogenesis
biomarkers
early diagnosis
air pollution
biomarker
exposure
human
lung cancer
miRNA
carcinogenesis
microRNA
asbestos exposure
oral squamous cell carcinoma
diagnosis
prognosis
saliva
neuroblastoma
MYCN amplification
metastases
chemoresistance
public health genomics
genetic polymorphisms
epigenetic modulations
genetic and microbiome markers
health technology assessment
early disease prevention
nonsmokers lung cancer
environmental risk factors
oncogenes
mutations
glioblastoma
microRNAs
cancer
qPCR
cancer stem cells
plasticizers
in vitro study
PRISMA
no-smokers lung cancer
DNA adducts
mesothelioma
extracellular vesicles
miR-625
fluoro-edenite
asbestos
malignant mesothelioma
cancer prevention
microbiota
epigenetics
environmental pollutants
cutaneous tissues
ozone exposure
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910576878603321
Pulliero Alessandra  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Strategies to Improve Antineoplastic Activity of Drugs in Cancer Progression
Strategies to Improve Antineoplastic Activity of Drugs in Cancer Progression
Autore Stefanachi Angela
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (416 p.)
Soggetto topico Research & information: general
Biology, life sciences
Soggetto non controllato EGR-1
flavonoid
(E)-5-((4-oxo-4H-chromen-3-yl)methyleneamino)-1-phenyl-1H-pyrazole-4-carbonitrile
MDA-MB-231
MMP9
TNFα
pancreatic ductal adenocarcinoma
cyclodextrin inclusion complex
phase solubility studies
preformulation studies
biphenylnicotinamide derivatives
dual inhibitor
EGFR
VEGFR2
ligand-based pharmacophore
molecular docking
molecular dynamics
leukemias
doxorubicin
inflammation
drug delivery
tumor targeting
elastin-like polypeptide
cell penetrating peptide
matrix metalloproteinase
doxorubicin resistance
photosensitizer delivery system
PAMAM dendrimer
photodynamic therapy
cytotoxicity
phototoxicity
colorectal adenocarcinoma
dicarboximides
chemical synthesis
apoptosis
kinases
anticancer
gene profiling
SAR
biomarkers
colorectal cancer
early detection examination
liquid biopsy
personalized medicine
tumor treatment
exosomes
ctDNA
CTC
cytotoxic activity
pyrazole derivatives
MTT assay
ADMET analysis
single-crystal diffraction
FTIR spectroscopy
NMR spectroscopy thermogravimetric analysis
acute myelogenous leukemia
platelets
microparticles
γδ T cells
immunotherapy
tumor resistance
combination therapy
tumor microenvironment
immune checkpoint inhibitor
neuroblastoma
molecular iodine
cyclophosphamide
xenografts
metronomic therapy
tamoxifen
CYP2D6
MCF-7
Ishikawa cells
SERM
TNBC
uterotrophic
α-mangostin
poly(amidoamine) dendrimer
targeted drug delivery
biotin targeting
glioblastoma multiforme
squamous cell carcinoma
antiparasitic therapy
diclofenac
indomethacin
oleanolic acid derivative conjugates
NF-κB
Nrf2
MAPKs
PSN-1 cells
reactive oxygen species
glioblastoma
brain tumor
extracellular vesicles
pancreatic cancer
paclitaxel
clathrin
endocytosis
sulforaphane
nicotine
metalloproteinase-9
gastric cancer
cell invasion
Arylquin 1
colon cancer
tumor progression
azelastine
oxidative stress
autophagy
mitotic catastrophe
chronic myeloid leukemia
imatinib
tyrosine kinase
ketoconazole
P-glycoprotein
drug efflux transporter
non-small-cell lung cancer
cisplatin resistance
aldehyde dehydrogenase
isothiocyanates
disulfiram
epithelial to mesenchymal transition
aminopeptidase N
acetamidophenones
Schiff bases
semicarbazones
thiosemicarbazones
inhibition of proliferation
ISBN 3-0365-5927-2
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910639990003321
Stefanachi Angela  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Systems Radiology and Personalized Medicine
Systems Radiology and Personalized Medicine
Autore de Jong Pim A
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (180 p.)
Soggetto topico Medicine
Soggetto non controllato COVID-19
chest X-ray
deep learning
convolutional neural network
Grad-CAM
computed tomography
image analysis
osteoarthritis
reliability
FDG-PET/CT
infection
bloodstream infection
endocarditis
vascular graft infection
spondylodiscitis
cyst infection
white blood cell scintigraphy
total body PET/CT
radiotracers
artificial intelligence
contrast media
body composition
large vessel vasculitis
atherosclerosis
imaging
FDG-PET
radiological imaging
MRI
non-contrast
venography
TRANCE
QFlow
neuroblastoma
nuclear medicine
radionuclide imaging
[123I]mIBG
[124I]mIBG
[18F]mFBG
[18F]FDG
[68Ga]Ga-DOTA peptides
[18F]F-DOPA
[11C]mHED
chronic limb-threatening ischemia
peripheral arterial disease
calcification pattern
diffuse idiopathic skeletal hyperostosis
risk factors
adiposity
intra-abdominal fat
cardiorenal syndrome
imaging biomarker
tissue characterization
cerebral aneurysm
computational fluid dynamics
hemodynamic
morphological
rupture
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557748903321
de Jong Pim A  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Tea in Health and Disease
Tea in Health and Disease
Autore Dou Q. Ping
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica 1 electronic resource (222 p.)
Soggetto non controllato polyphenols
cell cycle arrest and apoptosis
neuroblastoma
salivary ?-amylase activity
cancer apoptosis
yaupon holly
bioaccessibility
fracture
p53
tea
Liubao tea
BE(2)-C
matrix metalloproteinase-1 (MMP-1)
catechin
renal stone
oxalate
protein expression
67LR
Alzheimer's disease
EGCG
nutraceutical
diseases
anti-oxidant
heme oxygenase-1
polyphenol
anxiety
matcha
ERCC1/XPF
neuro-sphere
tea consumption
theanine
Rosmarinic acid
yerba mate
hypercalciuria
gene expression
microbiota
cohort study
histone deacetylase 2 (HDAC2)
guayusa
nuclear factor erythroid 2-related factor 2 (Nrf2)
DNA repair
mRNA expression
caffeine
chemoprevention
cisplatin
6-OH-11-O-hydroxyphenanthrene
adrenal hypertrophy
hepatic damage
anti-photoaging
cell death
green tea
kudingcha
suberoylanilide hydroxamic acid (SAHA)
epigallocatechin gallate (EGCG)
stress-reduction
calcium oxalate monohydrate
Camellia sinensis
chemoresistance
tea polyphenols
green tea polyphenols
green tea catechins
N-MYC
cancer
epigallocatechin-gallate (EGCG)
Parkinson's disease
ISBN 3-03897-987-2
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910346684203321
Dou Q. Ping  
MDPI - Multidisciplinary Digital Publishing Institute, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Venom and Toxin as Targeted Therapy
Venom and Toxin as Targeted Therapy
Autore Kwok Hang Fai (Henry)
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica 1 electronic resource (180 p.)
Soggetto non controllato cane toad
B cell non-Hodgkin lymphoma
Malaysian cobras
complement system
decay accelerating factor
neuroblastoma
atopic dermatitis
complement dependent cytotoxicity
antioxidant enzymes
bacterial adhesion
cancer therapy
N. kaouthia
anuran skin secretion
frog
Apis mellifera syriaca
solid phase extraction
bee venom phospholipase A2 (bvPLA2)
disintegrin
toad toxins
immunotoxins
ribosome-inactivating proteins
antimicrobial peptide (AMP)
drug design
Moxetumomab pasudotox
snake venom
antiviral activity
in vitro effects
bombesin-related peptide
oxidative stress biomarkers
half-life
blood vessel formation
target therapy
2
MYCN
indolealkylamines
Huachansu
membrane attack complex
bouganin
bee venom
SEM
anticancer activity
antimicrobial peptide
house dust mite extract (DFE)
mannose receptor
O. hannah
bicarinalin
gastric cells
melittin
LC-ESI-MS
dermaseptin
smooth muscle
apoptosis
anticancer
N. sumatrana
Helicobacter pylori
inflammation
immunotherapy
atopic dermatitis (AD)
immunotoxin
mantle cell lymphoma
clearance
mass spectrometry
Bougainvillea
rRNA N-glycosylase activity
fungal toxin
skin inflammation
targeted therapy
4-dinitrochlorobenzene (DNCB)
Bee venom
VEGF
Chansu
bufadienolides
obsessive-compulsive disorder (OCD)
BLF1
antimicrobial activity
orellanine
VB6-845
acute lymphoblastic leukemia
ribosome-inactivating protein
CD206
molecular cloning
cancer
CD22
eIF4A
ISBN 3-03921-190-0
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910367754703321
Kwok Hang Fai (Henry)  
MDPI - Multidisciplinary Digital Publishing Institute, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui